Literature DB >> 22999502

Cancer of the corpus uteri.

Frédéric Amant1, Mansoor Raza Mirza, Carien L Creutzberg.   

Abstract

Mesh:

Year:  2012        PMID: 22999502     DOI: 10.1016/S0020-7292(12)60024-1

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  14 in total

1.  Pre-operative MRI staging of endometrial cancer in a multicentre cancer network: can we match single centre study results?

Authors:  N D Soneji; N Bharwani; A Ferri; V Stewart; A Rockall
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

2.  Assessment of deep myometrial invasion of endometrial cancer on MRI: added value of second-opinion interpretations by radiologists subspecialized in gynaecologic oncology.

Authors:  Sungmin Woo; Sang Youn Kim; Jeong Yeon Cho; Seung Hyup Kim
Journal:  Eur Radiol       Date:  2016-09-21       Impact factor: 5.315

3.  Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer.

Authors:  Fengjuan Xu; Su'an Sun; Shilan Yan; Hongling Guo; Miao Dai; Yincheng Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis.

Authors:  Anita Andreano; Gilda Rechichi; Paola Rebora; Sandro Sironi; Maria Grazia Valsecchi; Stefania Galimberti
Journal:  Eur Radiol       Date:  2014-03-26       Impact factor: 5.315

5.  Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer.

Authors:  Ozan C Guler; Cem Onal; Ibrahim Acibuci
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

6.  Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).

Authors:  Nathalie Arians; Robert Foerster; Joachim Rom; Matthias Uhl; Falk Roeder; Jürgen Debus; Katja Lindel
Journal:  Radiat Oncol       Date:  2016-03-18       Impact factor: 3.481

7.  Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer.

Authors:  Sylwia Kellas-Ślęczka; Piotr Wojcieszek; Brygida Białas
Journal:  J Contemp Brachytherapy       Date:  2012-12-28

8.  Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.

Authors:  Henrica M J Werner; Jone Trovik; Mari K Halle; Elisabeth Wik; Lars A Akslen; Even Birkeland; Therese Bredholt; Ingvild L Tangen; Camilla Krakstad; Helga B Salvesen
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

9.  Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.

Authors:  Toshio Nishimura; Kazuto Nakamura; Soichi Yamashita; Sadatomo Ikeda; Keiko Kigure; Takashi Minegishi
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

10.  Evaluating Myometrial Invasion in Endometrial Cancer: Comparison of Reduced Field-of-view Diffusion-weighted Imaging and Dynamic Contrast-enhanced MR Imaging.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Masafumi Harada
Journal:  Magn Reson Med Sci       Date:  2017-05-18       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.